SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,809,402 | -33.4% | 138,172 | -27.3% | 0.70% | -29.6% |
| Q2 2023 | $5,716,781 | +19.6% | 190,179 | +44.2% | 0.99% | -4.6% |
| Q1 2023 | $4,777,940 | +41.1% | 131,878 | +39.0% | 1.04% | +15.3% |
| Q4 2022 | $3,385,297 | +11.5% | 94,906 | +5.8% | 0.90% | +4.4% |
| Q3 2022 | $3,037,000 | +18.4% | 89,709 | +1.2% | 0.86% | -8.6% |
| Q2 2022 | $2,564,000 | -27.2% | 88,658 | -18.6% | 0.94% | -8.3% |
| Q1 2022 | $3,521,000 | +15.3% | 108,954 | +4.0% | 1.03% | +52.8% |
| Q4 2021 | $3,053,000 | +14.0% | 104,714 | +4.3% | 0.67% | -0.6% |
| Q3 2021 | $2,678,000 | -13.4% | 100,415 | 0.0% | 0.68% | +0.3% |
| Q2 2021 | $3,092,000 | – | 100,415 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |